Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant.

EBioMedicine · 2015 · PMC4465122 · PMID 26086037

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although tumor inhibition by rhPEPD at the low dose was not statistically significant, other effects of rhPEPD at this dose level were highly significant, as shown below.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.